81 FR 65663 - Submission for OMB Review; 30-Day Comment Request; Palliative Care: Conversations Matter® Phase Two Evaluation (National Institute of Nursing Research)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 185 (September 23, 2016)

Page Range		65663-65664
FR Document		2016-22998

In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on July 12, 2016, page 45169 (81 FR 45169) and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment.

Federal Register, Volume 81 Issue 185 (Friday, September 23, 2016)

[Federal Register Volume 81, Number 185 (Friday, September 23, 2016)]
[Notices]
[Pages 65663-65664]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-22998]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request; Palliative 
Care: Conversations Matter[supreg] Phase Two Evaluation (National 
Institute of Nursing Research)

AGENCY: National Institutes of Health, Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the 
National Institutes of Health (NIH) has submitted to the Office of 
Management and Budget (OMB) a request for review and approval of the 
information collection listed below. This proposed information 
collection was previously published in the Federal Register on July 12, 
2016, page 45169 (81 FR 45169) and allowed 60 days for public comment. 
No public comments were received. The purpose of this notice is to 
allow an additional 30 days for public comment.

DATES: Comments regarding this information collection are best assured 
of having their full effect if received within 30 days of the date of 
this publication.

ADDRESSES: Written comments and/or suggestions regarding the item(s) 
contained in this notice, especially regarding the estimated public 
burden and associated response time, should be directed to the: Office 
of Management and Budget, Office of Regulatory Affairs, 
[email protected] or by fax to (202) 395-6974, Attention: 
Desk Officer for NIH.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the data collection plans and 
instruments, contact: Ms. Diana Finegold, Office of Communications and 
Public Liaison, NINR, NIH, Building 31, Suite 5B03, 31 Center Drive, 
Bethesda, MD 20892, or call non-toll-free number (301) 496-0209, or 
Email your request, including your address to: [email protected].

SUPPLEMENTARY INFORMATION: The National Institute of Nursing Research 
(NINR), National Institutes of Health, may not conduct or sponsor, and 
the respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number.
    In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction 
Act of 1995, the National Institutes of Health (NIH) has submitted to 
the Office of Management and Budget (OMB) a request for review and 
approval of the information collection listed below.
    Proposed Collection: Palliative Care: Conversations Matter[supreg] 
Phase Two Evaluation, 0925-0683, National Institute of Nursing Research 
(NINR), National Institutes of Health (NIH).
    Need and Use of Information Collection: The NINR Palliative Care: 
Conversations Matter[supreg] initiative, which launched in FY 2014, is 
now in its second phase. The first phase was focused on providing 
materials and tools to assist health care providers in having sometimes 
difficult conversations with children and families about palliative 
care. The second phase of the campaign, launched in FY 2015, focuses on 
children, parents, and families. The Palliative Care: Conversations 
Matter[supreg] Phase Two evaluation will assess the information and 
materials being disseminated to children, parents, and families. Survey 
findings will help (1) determine if the campaign is effective, 
relevant, and useful to the families and caregivers of children living 
with serious illnesses; (2) to better understand the information needs 
of families and caregivers to inform future campaign efforts; and (3) 
examine how effective the campaign materials are in providing families 
and caregivers with information on palliative care.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 371 hours.

[[Page 65664]]



                                 Table A-12-1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total annual
         Form name          Type of  respondents    respondents    responses per   response (in    burden hours
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Screener..................  Parents and                   10,000               1            2/60             333
                             Caregivers.
Main Survey...............  Parents and                      150               1           15/60              38
                             Caregivers of
                             Children with
                             Serious Illnesses--
                             Completes.
rrrrrrrrrrrrrrrrrrrrrrrrrrr
    Total.................  ....................          10,150          10,150  ..............             371
----------------------------------------------------------------------------------------------------------------


    Dated: September 13, 2016.
Diana Finegold,
Project Clearance Liaison, NINR, NIH.
[FR Doc. 2016-22998 Filed 9-22-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 185 / Friday, September 23, 2016 / Notices 65663

should be directed to: Susan Ano, Ph.D., Dated: September 19, 2016. Suite 5B03, 31 Center Drive, Bethesda,
NINDS Technology Transfer, 31 Center Susan Ano, MD 20892, or call non-toll-free number
Drive, Suite 8A52, MS2540, Bethesda, Technology Development Coordinator, (301) 496–0209, or Email your request,
MD 20892; Telephone: (301) 435–5515; NINDS Technology Transfer, National including your address to:
Email: anos@mail.nih.gov. Institutes of Health. Diana.Finegold@nih.gov.
[FR Doc. 2016–22897 Filed 9–22–16; 8:45 am] SUPPLEMENTARY INFORMATION: The
SUPPLEMENTARY INFORMATION: This BILLING CODE 4140–01–P National Institute of Nursing Research
invention discloses treating
(NINR), National Institutes of Health,
neurodegenerative diseases by
may not conduct or sponsor, and the
administering cyclin dependent kinase DEPARTMENT OF HEALTH AND respondent is not required to respond
5 (Cdk5) inhibitory peptides derived HUMAN SERVICES to, an information collection that has
from P35, the activator of Cdk5. been extended, revised, or implemented
Abnormally hyperactive Cdk5 has been National Institutes of Health
on or after October 1, 1995, unless it
shown to be associated with a variety of displays a currently valid OMB control
Submission for OMB Review; 30-Day
neurodegenerative disorders. This Comment Request; Palliative Care: number.
invention describes isolated peptide Conversations Matter® Phase Two In compliance with Section
fragments, pharmaceutical compositions Evaluation (National Institute of 3507(a)(1)(D) of the Paperwork
and methods for use of such for treating Nursing Research) Reduction Act of 1995, the National
subjects with a neurodegenerative Institutes of Health (NIH) has submitted
disease, such as Alzheimer’s disease AGENCY: National Institutes of Health, to the Office of Management and Budget
(AD), Amyotrophic Lateral Sclerosis Department of Health and Human (OMB) a request for review and
(ALS) and Parkinson’s disease (PD). An Services. approval of the information collection
inhibitory fragment, TFP5, disclosed in ACTION: Notice. listed below.
this invention, has been shown to Proposed Collection: Palliative Care:
SUMMARY: In compliance with the
ameliorate symptoms of AD in disease Conversations Matter® Phase Two
Paperwork Reduction Act of 1995, the
animal models without any evidence of Evaluation, 0925–0683, National
National Institutes of Health (NIH) has
toxicity. In particular, TFP5 treatment of Institute of Nursing Research (NINR),
submitted to the Office of Management
rat cortical neurons reduced National Institutes of Health (NIH).
and Budget (OMB) a request for review
hyperactivation of Cdk5 upon neuronal Need and Use of Information
and approval of the information
stress and insults. Following Collection: The NINR Palliative Care:
collection listed below. This proposed
intraperitoneal (ip) injection, TFP5 was Conversations Matter® initiative, which
information collection was previously
capable of crossing the blood-brain published in the Federal Register on launched in FY 2014, is now in its
July 12, 2016, page 45169 (81 FR 45169) second phase. The first phase was
barrier and localizing within the brain
and allowed 60 days for public focused on providing materials and
where it was found to rescue memory
comment. No public comments were tools to assist health care providers in
deficits and pathology in a double having sometimes difficult
transgenic mouse (APP/PS1) AD model. received. The purpose of this notice is
to allow an additional 30 days for public conversations with children and
The prospective start-up exclusive families about palliative care. The
comment.
license may be granted unless within second phase of the campaign, launched
DATES: Comments regarding this
fifteen (15) days from the date of this in FY 2015, focuses on children,
information collection are best assured parents, and families. The Palliative
published notice, the NIH receives
of having their full effect if received Care: Conversations Matter® Phase Two
written evidence and argument that
within 30 days of the date of this evaluation will assess the information
establishes that the grant of the license
publication. and materials being disseminated to
would not be consistent with the
requirements of 35 U.S.C. 209 and 37 ADDRESSES: Written comments and/or children, parents, and families. Survey
CFR part 404. suggestions regarding the item(s) findings will help (1) determine if the
contained in this notice, especially campaign is effective, relevant, and
Complete applications for a license in regarding the estimated public burden useful to the families and caregivers of
the field of use filed in response to this and associated response time, should be children living with serious illnesses;
notice will be treated as objections to directed to the: Office of Management (2) to better understand the information
the grant of the contemplated start-up and Budget, Office of Regulatory Affairs, needs of families and caregivers to
exclusive license. Comments and OIRA_submission@omb.eop.gov or by inform future campaign efforts; and (3)
objections submitted to this notice will fax to (202) 395–6974, Attention: Desk examine how effective the campaign
not be made available for public Officer for NIH. materials are in providing families and
inspection and, to the extent permitted FOR FURTHER INFORMATION CONTACT: To caregivers with information on
by law, will not be released under the request more information on the palliative care.
Freedom of Information Act, 5 U.S.C. proposed project or to obtain a copy of OMB approval is requested for 3
552. the data collection plans and years. There are no costs to respondents
instruments, contact: Ms. Diana other than their time. The total
Finegold, Office of Communications and estimated annualized burden hours are
sradovich on DSK3GMQ082PROD with NOTICES

Public Liaison, NINR, NIH, Building 31, 371 hours.

VerDate Sep<11>2014 18:22 Sep 22, 2016 Jkt 238001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\23SEN1.SGM 23SEN1

65664 Federal Register / Vol. 81, No. 185 / Friday, September 23, 2016 / Notices

TABLE A–12–1—ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Type of Number of burden per Total annual
Form name responses per
respondents respondents response burden hours
respondent (in hours)

Screener ........... Parents and Caregivers .................................................... 10,000 1 2/60 333
Main Survey ...... Parents and Caregivers of Children with Serious Ill- 150 1 15/60 38
nesses—Completes.

Total ........... ........................................................................................... 10,150 10,150 ........................ 371

Dated: September 13, 2016. Contact Person: Michael B. Small, Ph.D., 7W234, Bethesda, MD 20892–9750, 240–276–
Diana Finegold, Chief, Program and Review Extramural Staff 6368, stoicaa2@mail.nih.gov.
Project Clearance Liaison, NINR, NIH. Training Office (PRESTO), Program and Name of Committee: National Cancer
Review Extramural Staff Training Office, Institute Special Emphasis Panel; Member
[FR Doc. 2016–22998 Filed 9–22–16; 8:45 am] Division of Extramural Activities, National Conflict SEP.
BILLING CODE 4140–01–P Cancer Institute, NIH, 9609 Medical Center Date: November 10, 2016.
Drive, 7W412, Bethesda, MD 20892–9750, Time: 12:30 p.m. to 2:30 p.m.
240–276–6438, smallm@mail.nih.gov. Agenda: To review and evaluate grant
DEPARTMENT OF HEALTH AND Name of Committee: National Cancer applications.
HUMAN SERVICES Institute Special Emphasis Panel; NCI Place: National Cancer Institute, Shady
Omnibus SEP–1. Grove, 9609 Medical Center Drive, Room
National Institutes of Health Date: October 27–28, 2016. 7W238, Rockville, MD 20850 (Telephone
Time: 8:00 a.m. to 2:00 p.m. Conference Call).
National Cancer Institute; Notice of Agenda: To review and evaluate grant Contact Person: Byeong-Chel Lee, Ph.D.,
Closed Meetings applications. Scientific Review Officer, Resources and
Place: Bethesda North Marriott Hotel & Training Review Branch, Division of
Pursuant to section 10(d) of the Conference Center, 5701 Marinelli Road, Extramural Activities, National Cancer
Federal Advisory Committee Act, as North Bethesda, MD 20852. Institute, NIH, 9609 Medical Center Drive,
amended (5 U.S.C. App.), notice is Contact Person: Jennifer C Schiltz, Ph.D., 7W238, Rockville, MD 20850, 240–276–7755,
hereby given of the following meetings. Scientific Review Officer, Special Review byeong-chel.lee@nih.gov.
The meetings will be closed to the Branch, Division of Extramural Activities, (Catalogue of Federal Domestic Assistance
public in accordance with the National Cancer Institute, NIH, 9609 Medical Program Nos. 93.392, Cancer Construction;
provisions set forth in sections Center Drive, 7W634, Bethesda, MD 20892– 93.393, Cancer Cause and Prevention
9750, 240–276–5864, jennifer.schiltz@ Research; 93.394, Cancer Detection and
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
nih.gov. Diagnosis Research; 93.395, Cancer
as amended. The grant applications and
Name of Committee: National Cancer Treatment Research; 93.396, Cancer Biology
the discussions could disclose
Institute Special Emphasis Panel; Research; 93.397, Cancer Centers Support;
confidential trade secrets or commercial Quantitative Imaging for the Evaluation of 93.398, Cancer Research Manpower; 93.399,
property such as patentable material, Responses to Cancer Therapies. Cancer Control, National Institutes of Health,
and personal information concerning Date: November 2, 2016. HHS)
individuals associated with the grant Time: 11:00 a.m. to 5:00 p.m.
applications, the disclosure of which Dated: September 19, 2016.
Agenda: To review and evaluate grant
would constitute a clearly unwarranted applications. Melanie J. Gray,
invasion of personal privacy. Place: National Cancer Institute, Shady Program Analyst, Office of Federal Advisory
Grove, 9609 Medical Center Drive, Room Committee Policy.
Name of Committee: National Cancer 2W030, Rockville, MD 20850 (Telephone
Institute Initial Review Group; Subcommittee [FR Doc. 2016–22896 Filed 9–22–16; 8:45 am]
Conference Call).
I—Transition to Independence. BILLING CODE 4140–01–P
Contact Person: Kenneth L. Bielat, Ph.D.,
Date: October 18–19, 2016.
Scientific Review Officer, Research and
Time: 8:00 a.m. to 5:00 p.m.
Technology and Contract Review Branch,
Agenda: To review and evaluate grant DEPARTMENT OF HOMELAND
Division of Extramural Activities, National
applications.
Place: Ritz-Carlton Hotel at Pentagon City, Cancer Institute, NIH, 9609 Medical Center SECURITY
1250 South Hayes Street, Arlington, VA Drive, 7W244, Rockville, MD 20850, 240–
22202. 276–6373, bielatk@mail.nih.gov. Federal Emergency Management
Contact Person: Delia Tang, MD, Scientific Name of Committee: National Cancer Agency
Review Officer, Research Programs Review Institute Special Emphasis Panel; Research
[Docket ID FEMA–2016–0022]
Branch, Division of Extramural Activities, Centers for Cancer Systems Biology
National Cancer Institute, NIH, 9609 Medical Consortium (U54).
Revisions to the Public Assistance
Center Drive, 7W602, Bethesda, MD 20892– Date: November 9–10, 2016.
9750, 240–276–6456, tangd@mail.nih.gov. Time: 8:00 a.m. to 6:00 p.m. Program and Policy Guide
Name of Committee: National Cancer Agenda: To review and evaluate grant AGENCY: Federal Emergency
Institute Special Emphasis Panel; Planning applications. Management Agency, DHS.
Place: Bethesda North Marriott Hotel &
sradovich on DSK3GMQ082PROD with NOTICES

Grants for Global Research Infrastructure in ACTION: Notice of availability; request
Non-Communicable Disease 1. Conference Center, Montgomery County
Date: October 25, 2016. Conference Center Facility, 5701 Marinelli for comments.
Time: 8:00 a.m. to 5:00 p.m. Road, North Bethesda, MD 20852.
Contact Person: Adriana Stoica, Ph.D., SUMMARY: The Federal Emergency
Agenda: To review and evaluate grant
applications. Scientific Review Officer, Resources and Management Agency (FEMA) is
Place: Hyatt Regency Bethesda, One Training Review Branch, Division of accepting comments on proposed
Bethesda Metro Center, 7400 Wisconsin Extramural Activities, National Cancer revisions to the Public Assistance
Avenue, Bethesda, MD 20814. Institute, NIH, 9609 Medical Center Drive, Program and Policy Guide (PAPPG).

VerDate Sep<11>2014 18:22 Sep 22, 2016 Jkt 238001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\23SEN1.SGM 23SEN1

Document Created: 2016-09-23 01:43:52
Document Modified: 2016-09-23 01:43:52

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.
Contact		To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Ms. Diana Finegold, Office of Communications and Public Liaison, NINR, NIH, Building 31, Suite 5B03, 31 Center Drive, Bethesda, MD 20892, or call non-toll-free number (301) 496-0209, or
FR Citation		81 FR 65663

81 FR 65663 - Submission for OMB Review; 30-Day Comment Request; Palliative Care: Conversations Matter® Phase Two Evaluation (National Institute of Nursing Research)

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 185 (September 23, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health